FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Vasodrine 5 mg tablet
Vasodrine 5 mg tablet, 500, blister pack
Vasodrine 5 mg tablet, 60, blister pack
Vasodrine 5 mg tablet, 90, blister pack
Vaxelis injection, 0.5 mL syringe
Vaxelis injection, 0.5 mL vial
Vaxelis injection, 0.5 mL syringe
Vaxelis injection, 10 x 0.5 mL syringes
Vaxelis injection, 10 x 0.5 mL vials
Vaxzevria Multidose injection, 10 x 4 mL vials
Vaxzevria Multidose injection, 10 x 5 mL vials
Vaxzevria Multidose injection, 4 mL vial
Vaxzevria Multidose injection, 5 mL vial
Veklury 100 mg/20 mL injection, 1 x 20 mL vial
Veklury 100 mg/20 mL injection, 20 mL vial
Veklury 100 mg powder for injection, 1 vial
Veklury 100 mg powder for injection, 100 mg vial
Venclexta 10 mg tablet
Venclexta 10 mg tablet, 14, blister pack
Venclexta 10 mg tablet, 2, blister pack
Venclexta 100 mg tablet
Venclexta 100 mg tablet, 1, blister pack
Venclexta 100 mg tablet, 112, blister pack
Venclexta 100 mg tablet, 120, bottle
Venclexta 100 mg tablet, 14, blister pack
Venclexta 100 mg tablet, 180, bottle
Venclexta 100 mg tablet, 2, bottle
Venclexta 100 mg tablet, 7, blister pack
Venclexta 50 mg tablet
Venclexta 50 mg tablet, 1, blister pack
Venclexta 50 mg tablet, 7, blister pack
Venclexta Starting Pack (venetoclax 50 mg) tablet [7 tablets] (&) (venetoclax 10 mg) tablet [14 tablets] (&) (venetoclax 100 mg) tablet [7 tablets] (&) (venetoclax 100 mg) tablet [14 tablets], 1 pack (containered trade product pack)
Verquvo 10 mg tablet
Verquvo 10 mg tablet, 100, blister pack
Verquvo 10 mg tablet, 14, blister pack
Verquvo 10 mg tablet, 28, blister pack
Verquvo 2.5 mg tablet
Verquvo 2.5 mg tablet, 100, blister pack
Verquvo 2.5 mg tablet, 14, blister pack
Verquvo 2.5 mg tablet, 28, blister pack
Verquvo 5 mg tablet
Verquvo 5 mg tablet, 100, blister pack
Verquvo 5 mg tablet, 14, blister pack
Verquvo 5 mg tablet, 28, blister pack
Verzenio 100 mg tablet
Verzenio 100 mg tablet, 14, blister pack
Verzenio 100 mg tablet, 42, blister pack
Verzenio 100 mg tablet, 56, blister pack
Verzenio 100 mg tablet, 70, blister pack
Verzenio 150 mg tablet
Verzenio 150 mg tablet, 14, blister pack
Verzenio 150 mg tablet, 42, blister pack
Verzenio 150 mg tablet, 56, blister pack
Verzenio 150 mg tablet, 70, blister pack
Verzenio 200 mg tablet
Verzenio 200 mg tablet, 14, blister pack
Verzenio 200 mg tablet, 42, blister pack
Verzenio 200 mg tablet, 56, blister pack
Verzenio 200 mg tablet, 70, blister pack
Verzenio 50 mg tablet
Verzenio 50 mg tablet, 14, blister pack
Verzenio 50 mg tablet, 42, blister pack
Verzenio 50 mg tablet, 56, blister pack
Verzenio 50 mg tablet, 70, blister pack
Veyvondi (1 x 1300 units vial, 1 x 10 mL inert diluent vial), 1 pack
Veyvondi (1 x 650 units vial, 1 x 5 mL inert diluent vial), 1 pack
Veyvondi (inert substance) diluent, 10 mL vial
Veyvondi (inert substance) diluent, 5 mL vial
Veyvondi (vonicog alfa 1300 units) powder for injection, 1300 units vial
Veyvondi (vonicog alfa 650 units) powder for injection, 650 units vial
Vitrakvi 100 mg capsule
Vitrakvi 100 mg capsule, 56, bottle
Vitrakvi 20 mg/mL oral liquid
Vitrakvi 20 mg/mL oral liquid, 100 mL, bottle
Vitrakvi 20 mg/mL oral liquid, 2 x 50 mL, bottles
Vitrakvi 20 mg/mL oral liquid, 50 mL, bottle
Vitrakvi 25 mg capsule
Vitrakvi 25 mg capsule, 56, bottle
Vocabria 30 mg tablet
Vocabria 30 mg tablet, 30, bottle
Vosevi tablet
Vosevi tablet, 28, bottle
Voxzogo (10 x 400 microgram vials, 10 x 0.5 mL inert diluent syringes), 1 pack
Voxzogo (10 x 1.2 mg vials, 10 x 0.6 mL inert diluent syringes), 1 pack
Voxzogo (10 x 560 microgram vials, 10 x 0.7 mL inert diluent syringes), 1 pack
Voxzogo (vosoritide 1.2 mg) powder for injection, 1.2 mg vial
Voxzogo (vosoritide 400 microgram) powder for injection, 400 microgram vial
Voxzogo (vosoritide 560 microgram) powder for injection, 560 microgram vial
Vsiqq 6 mg/0.05 mL intraocular injection, 0.05 mL vial
Vsiqq 6 mg/0.05 mL intraocular injection, 0.05 mL vial
Vumerity 231 mg enteric capsule
Vumerity 231 mg enteric capsule, 120, bottle
Vyepti 100 mg/mL injection, 1 mL vial
Vyepti 100 mg/mL injection, 1 mL vial
Vyndamax 61 mg capsule
Vyndamax 61 mg capsule, 30, blister pack
Vyndaqel 20 mg capsule
Vyndaqel 20 mg capsule, 30, blister pack
Vyxeos powder for injection, 1 vial
Vyxeos powder for injection, 2 vials
Vyxeos powder for injection, vial

Start Previous Page 13 of 15 Next End


Reference Sets

Reference set descriptor

Back to Start